期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

β受体阻滞剂心肌保护作用的研究 被引量：14

Study of Beta-adrenoceptor Antagonists on Cardiac Protection
下载PDF
导出
摘要 β受体阻滞剂广泛应用于临床治疗高血压、冠心病及心律失常。近年来 ,其心肌保护作用倍受人们的关注。本文就 β受体阻滞剂心肌保护作用的理论基础 ,在减少缺血再灌注损伤、纠正慢性充血性心力衰竭、保护血管功能等各个方面分别作一综述。 Beta-adrenoceptor antagonists are extensively used in the treatment of hypertension,coronary heart disease,and arrhythmia.Recently,the role of beta-adrenoceptor antagonists on cardiac protection are noticed.This article summarized the rationale for the cardiac protection of beta-blockers from all sides,such as inhibiting ischemical reperfusion injury,redressing chronic congestive heart failure,maintaining function of blood vessel and so on.
作者 厉泉 徐平
机构地区 青岛大学医学院附属医院心血管外科
出处 《心血管病学进展》 CAS 2005年第1期91-94,共4页 Advances in Cardiovascular Diseases
关键词 心肌保护作用 Β受体阻滞剂 血管功能 慢性充血性心力衰竭 缺血再灌注损伤 临床治疗 冠心病 Beta-adrenoceptor antagonist Ischemical reperfusion injury Heart failure
分类号 R96 [医药卫生—药理学]
  • 相关文献

参考文献27

  • 1Akhtar S,Barash PG.Perioperative use of beta-blockers:past,present,and future [J].Int Anesthesiol Clin,2002,40(2):133-157.
  • 2Dzimiri N.Regulation of beta-adrenoceptor signaling in cardiac function and disease [J].Pharmacol Rev,1999,51:465-501.
  • 3Guimaraes S,Moura D.Vascular adrenoceptors:an update [J].Pharmacol Rev 2001,53:319-356.
  • 4Dhalla NS,Temsah RM,Netticadan T.Role of oxidative stress in cardiovascular diseases [J].J Hypertens,2000,18(6):655-673.
  • 5Andona P,Karne R,Ghanim H,et al.Carvedilol inhibites reaction oxygen species generation by leukocytes and oxidative damage to amino acids[J].Circulation,2000,101:122-124.
  • 6Oettl K,Greilberger J,Zangger K,et al.Radical-scavenging and iron-chelating properties of carvedilol,an antihypertensive drug with antioxiodative activity[J].Biochem Pharmacol,2001,62(2):241-248.
  • 7Cargnoni A,Ceconi C,Bernocehi P,et al.Reduction of oxidative stress by carvedilol:role in maintenance of ischaemic myocardium viability[J].Cardiovasc Res,2000,47(3):556-566.
  • 8Oliveira PJ,Coxito PM,Rolo AP,et al.Inhibitory effect of carvedilol in the high-conductance state of the mitochondrial permeability transition pore [J].Eur J Pharmacol,2001,412(3):231-237.
  • 9Matsuda Y,Akita H,Terashima M,et al.Carvedilol improves endomelium-dependent dilatation in patients with coronary artery disease[J].Am Heart J,2000,140(5):753-759.
  • 10Jones SP,Girod WG,Palazzo AJ,et al.Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase[J].Am J Physiol,1999,276(5Pt2):H1567-H1573.

二级参考文献11

  • 1Packer M, Bristow M R, Cohn J N, et al. For the US carvedilol heart failure study group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure[J]. N Engl J Med, 1996,334(21) : 1349 -1355.
  • 2MERIT-HF study group. Effect of metroprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF) [J]. Lancet, 1999,353(9196):2001-2007.
  • 3Kim Y K, Kim S J, Kramer C M, et al. Altered excitation-contraction coupling in myocytes from remodeled myocardium after chronic myocardial inffarction[J]. J Mol Cell Cattdial, 2002,34(1):63-73.
  • 4Hasegawa K, Iwai-Kanai E, Sasayama S. Neurohormonal regulation of myocardial cell apoptosis during the development of heart failure[J]. J CellPhysiol, 2001,186( 1 ) : 11 - 18.
  • 5Singh K, Communal C, Sawyer D B, et al. Adrenergic regulation of myocardial aoootosis[J]. Cardiovasc Res, 2000,45(3) :713 - 719.
  • 6Drexler H, Depenbuseh J W, Truog A G, et al. Effocts of diltiazern on cardiac function and regional blood at rest and during exercise in a conscious rat preparation of chronic heart failure (myocardial iiffnretion) [J]. Circula-tion, 1985,71(6) : 1260 - 1270.
  • 7Afzal N, Dhalla N S. Different changes in left and fight ventfieular SR calcium transport in congestive heart failure[J]. Am J Physiol, 1992,262(4) :H868- H874.
  • 8Houser S R, Piacentino V, Weisser J. Abnormalities of calcium cycling in the hypertrophied and failing heart[J]. J Mol Cell Catrdiol, 2000,32(9):1595-1607.
  • 9De Windt L J, Lim H W, Taigen T, et al. Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and vivo : an apoptosis-independent model of dilated heart failure[ J]. Circ Res, 2000, 86(3) :255 - 263.
  • 10耿召华,李隆贵,黄坚,胡友勇,耿建萌,何作云,祝善俊.培哚普利对慢性心功能不全大鼠心肌肌浆网Ca^(2+)泵功能的影响[J].第三军医大学学报,2000,22(9):875-878. 被引量：1

共引文献4

同被引文献50

引证文献14

二级引证文献11

心血管病学进展
2005年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部